Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vials/shelf-pack (NDC 0641-6042-25), For IV or IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.
Published January 22, 2020 · Recall initiated: December 17, 2019
Summary
FDA records drug Class I recall D-0864-2020, published January 22, 2020 and initiated December 17, 2019. Recalling firm: Hikma Pharmaceuticals USA Inc.; Status: Terminated; Reported quantity: 101,710 25 vials/shelf-pack; Lot: Lot #: 038366, Exp. Date Mar 2020; 048365, 048367, Exp. Date Apr 2020; 078301, 078303, Exp. Date July 2020; 118358, Exp. Date Nov 2020; 029353, Exp. Date Feb 2021; 019413, Exp. Date Jan 2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
What to do
Voluntary: Firm initiated · Letter
Get an email if KETOROLAC TROMETHAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 038366, Exp. Date Mar 2020; 048365, 048367, Exp. Date Apr 2020; 078301, 078303, Exp. Date July 2020; 118358, Exp. Date Nov 2020; 029353, Exp. Date Feb 2021; 019413, Exp. Date Jan 2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular UseOctober 29, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc.,October 8, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto,July 2, 2025
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only,August 24, 2022
- FDALipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 mL (40 mg/mL) Sterile 30 mLJanuary 22, 2020
- FDAHOME CHEF HEAT & EAT Baked Macaroni & Cheese NET WT. 12 oz (340G) keep refrigerated, Distributed by: TheJanuary 22, 2020
Questions about this recall
Was Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vials/shelf-pack (NDC 0641-6042-25), For IV or IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA. recalled?
Yes. FDA published recall D-0864-2020 on January 22, 2020. Reported hazard: Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE.